Timely Reperfusion in Acute ST-segment Myocardial Infarction

Acute Myocardial Infarction Clinical Trial

Official title:

Mobilizing Clinical Leadership to Achieve Timely Reperfusion in Acute ST-segment Elevation Myocardial Infarction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04614805
• Other study ID #: iTide
• Status: Completed
• Start date: November 1, 2020
• Est. completion date: January 4, 2023

Study information

• Verified date: January 2023
• Source: University Hospital of North Norway
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.

Description:

In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 146
• Est. completion date: January 4, 2023
• Est. primary completion date: January 4, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)

Exclusion Criteria:

• Reperfusion therapy not indicated or contraindicated

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Infarction
• Myocardial Infarction

Intervention

Behavioral:
• Mobilizing clinical leaders
Clinical leaders and clinical personnel will regularly receive feedback regarding performance of their own hospital as well as other providers in the regional health trust of North Norway.

Locations

Country	Name	City	State
Norway	University Hospital North Norway	Tromsø	Troms Og Finnmark

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital of North Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time to reperfusion	Interval between 1st medical contact and opening of the infarction-related coronary artery.	This parameter will be recorded within 1 week after patient inclusion
Secondary	Ejection fraction at discharge	Systolic function of the left ventricle	This parameter will be recorded up to 6 months after patient inclusion
Secondary	Survival	Survival after 30 days from incident	This parameter will be collected from patient's records during Nov -20 till Aug -21.